Published in Am J Hematol on October 01, 2009
Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution. Ups J Med Sci (2012) 0.86
Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease. Ups J Med Sci (2013) 0.80
Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1. Ann Hematol (2014) 0.77
Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections. Arthritis Rheum (2011) 2.06
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant (2011) 1.90
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood (2002) 1.55
Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant (2011) 1.54
Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma (2009) 1.41
[Future care requires future ways of working]. Lakartidningen (2009) 1.39
Another view of animal friendly curriculums. J Am Vet Med Assoc (2004) 1.38
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma (2011) 1.27
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood (2012) 1.23
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant (2009) 1.15
Allogeneic hematopoietic stem cell transplantation for treatment of Gaucher disease. Pediatr Hematol Oncol (2013) 1.10
Hemophagocytic syndrome in children and adults. Arch Immunol Ther Exp (Warsz) (2014) 1.05
Gaucher disease with foamy transformed macrophages and erythrophagocytic activity. J Inherit Metab Dis (2010) 0.98
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant (2003) 0.98
Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1. Folia Histochem Cytobiol (2015) 0.96
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis. Med Oncol (2008) 0.95
Portal vein thrombosis is a common complication following splenectomy in patients with malignant haematological diseases. Eur J Haematol (2006) 0.91
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors. Clin Transplant (2013) 0.90
Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation. Med Oncol (2011) 0.87
Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution. Ups J Med Sci (2012) 0.86
Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study. Eur J Haematol (2003) 0.85
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007. Haematologica (2012) 0.85
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. Br J Haematol (2002) 0.85
Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1. Pol Arch Med Wewn (2014) 0.85
Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia. Leuk Lymphoma (2011) 0.83
Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes. Leuk Res (2005) 0.82
Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations. Haematologica (2012) 0.81
Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia. Br J Haematol (2007) 0.81
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use? Med Oncol (2007) 0.81
Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol (2013) 0.80
Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease. Ups J Med Sci (2013) 0.80
Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma. Med Oncol (2010) 0.80
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien Klin Wochenschr (2012) 0.80
Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells. Stem Cells Dev (2012) 0.80
High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden. Eur J Haematol (2014) 0.79
Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation. Oncol Rep (2009) 0.79
An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients. Haematologica (2008) 0.78
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival? Leuk Lymphoma (2012) 0.78
Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3. Arch Immunol Ther Exp (Warsz) (2014) 0.78
Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers. Med Oncol (2015) 0.77
Microvascular density in chronic pancreatitis and pancreatic ductal adenocarcinoma. Folia Histochem Cytobiol (2003) 0.77
Alemtuzumab treatment for hemophagocytic lymphohistiocytosis. Nat Rev Clin Oncol (2010) 0.77
Bone marrow derived cells in adult skeletal muscle tissue in humans. Skelet Muscle (2013) 0.77
Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1. Ann Hematol (2014) 0.77
Early access experience with VPRIV(®): recommendations for 'core data' collection. Blood Cells Mol Dis (2010) 0.77
Posttransplant lymphoma--a single-center experience of 500 liver transplantations. Med Oncol (2004) 0.76
Infection of domestic dogs in peru by zoonotic bartonella species: a cross-sectional prevalence study of 219 asymptomatic dogs. PLoS Negl Trop Dis (2013) 0.76
Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden. Leuk Lymphoma (2010) 0.76
Splenectomy as a therapeutic approach in refractory hemophagocytic lymphohistiocytosis. Biomed Pharmacother (2011) 0.76
Hemophagocytic lymphohistiocytosis in adults. Ups J Med Sci (2013) 0.75
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation. Clin Transl Allergy (2013) 0.75
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus. Acta Derm Venereol (2016) 0.75
Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results. Med Oncol (2011) 0.75
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study. Leuk Lymphoma (2011) 0.75
In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome. Stem Cells Transl Med (2016) 0.75
The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma. Eur J Haematol (2014) 0.75
Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process? Eur J Haematol (2012) 0.75
Bendamustine in combination with high-dose radiotherapy and thalidomide is effective in treatment of multiple myeloma with central nervous system involvement. Eur J Haematol (2014) 0.75
Mantle cell lymphoma successfully treated in a patient with multiple endocrine neoplasia type 2: a rare combination of two malignancies. Med Oncol (2012) 0.75
Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study. Am J Hematol (2011) 0.75
[Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis]. Lakartidningen (2012) 0.75
Is it possible to identify siblings by studying bone marrow under a microscope? Two unusual cases of Gaucher disease. Pol J Pathol (2002) 0.75